Parts I and Portions of registrant’s proxy statement for its 2023 annual meeting of shareholders filed within 120 days after the close of the registrant’s fiscal year III: (the “Proxy Statement”), are …

Find out how Johnson & Johnson is innovating to change the current treatment paradigm. More than 50 million people worldwide are affected by this common type of heart arrhythmia. Learn the facts …

In 2023, we delivered strong and sustained performance with 9.0% operational sales growth*, excluding the COVID-19 vaccine. Adjusted net earnings were $25.4 billion*. Adjusted diluted net earnings per …

Dec 31, 2023 · Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to …

Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well …

Johnson & Johnson does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Jan 1, 2023 · This Annual Report on Form 10-K and Johnson & Johnson’s other publicly available documents contain “forward-looking statements” within the meaning of the safe harbor provisions of …

View the Johnson & Johnson annual report 2023 below. Download this and previous annual reports by simply selecting the year. And read the PDF documents on your computer and mobile device. Use …

Get insights from Johnson & Johnson's 2023 annual report and investor relations material with Quarterlytics' easy-to-use platform. Explore now for free!

This Annual Report on Form 10-K and Johnson & Johnson’s other publicly available documents contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States …